Is an Allergy to a COVID Vaccine Always Real? Placebo Trial Casts Doubt
THURSDAY, March 2, 2023 (HealthDay) — Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real.In a small new study of 16 people who said they’d experienced …
Learn MoreRacism Brings Worse Heart Health for Black Women
THURSDAY, March 2, 2023 (HealthDay News) — Black women who are exposed to certain forms of racism may be more likely to develop heart disease, researchers say.Specifically, Black women who said they faced discrimination in employment, housing and in…
Learn MoreCancer Screenings Rise in States With Mandatory Paid Sick Leave
THURSDAY, March 2, 2023 (HealthDay News) — Many Americans are not getting recommended cancer screenings, and a new study hints at one way to push the needle: paid sick leave from work.Researchers found that in areas of the United States that passed m…
Learn MoreFDA Panel Backs Second RSV Vaccine for Older Americans
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in …
Learn MoreOlder Black Men Face Higher Risk of Death After Surgery
THURSDAY, March 2, 2023 (HealthDay News) — Older Black men are more likely than others to die after surgery, according to a new study. Black men have a higher chance of dying within 30 days of surgery compared to Black women and white adults, and the…
Learn MoreEli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35
WEDNESDAY, March 1, 2023 (HealthDay News) — More Americans will soon be paying less for their insulin. Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70 percent and cap out-of-pocket costs at $35 a mont…
Learn MoreFDA Panel Backs Pfizer RSV Vaccine for Older Americans
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisers on Tuesday recommended the approval of a respiratory syncytial virus (RSV) vaccine that could be used in Americans ages 60 years and older.The vac…
Learn MoreUn juez de Texas dictaminará sobre la pastilla para abortar
MARTES, 28 de febrero de 2023 (HealthDay News) — Que las mujeres puedan seguir obteniendo un aborto con medicamentos usando el fármaco mifepristona en Estados Unidos depende del dictamen inminente de un juez federal de Texas. El Juez de Distrito de E…
Learn More